Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

Tagged pharmaceuticals · clear

Ranbaxy and Astrazeneca Prevail in Nexium Pay for Delay Case

Written by Eric S. Furman, Ph.D. and Caleb A. Bates, Ph.D. On November 21, 2016, the U.S. Court of Appeals for the First Circuit upheld a 2014 jury verdict for AstraZeneca (AZ) and Ranbaxy regarding a 2012 payment of $700 million from AstraZeneca for…

December 22, 2016Unsorted2 min read

Unsorted

The battle over pharmaceutical patents and the Indian drug market

In the late 1990s, Novartis manufactured and patented imatinib (with the brand name Gleevec), a drug that prolongs life in patients with chronic myelogenous leukemia (CML). Since its release, imatinib has offered hope for patients suffering from (CML);…

March 15, 2012Unsorted5 min read